EV/EBITDA
-4.17
+0.11+2.57%
Wed, 05 Mar 2025 22:45:01 GMT
Summary
- As of March 6, 2025, DSGN EV/EBITDA is -4.17, with a rise of +0.11 (+2.57%) during the most recent trading day.
- Over the past year, DSGN EV/EBITDA has dropped by -2.18 (-109.55%).
- DSGN EV/EBITDA is now -300.96% below its all-time high of -1.04.
Performance
DSGN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
DSGN EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +2.6% | -2.4% | -2.2% |
1 m1 month | -36.7% | +36.6% | +31.8% |
3 m3 months | +16.8% | -16.7% | -15.3% |
6 m6 months | -18.5% | +13.5% | +5.6% |
ytdytd | +21.9% | -21.8% | -20.1% |
1 y1 year | -109.5% | +79.4% | +67.1% |
5 y5 years | - | - | - |
DSGN EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -39.0% | -4.28 | +2.6% | |
3 m | 3-month | -3.00 | -39.0% | -6.17 | +32.4% |
6 m | 6-month | -3.00 | -39.0% | -6.60 | +36.8% |
1 y | 1-year | -1.61 | -159.0% | -6.60 | +36.8% |
3 y | 3-year | -1.04 | -301.0% | -26.14 | +84.0% |
5 y | 5-year | -1.04 | -301.0% | -219.57 | +98.1% |
alltime | all time | -1.04 | -301.0% | -219.57 | +98.1% |
Design Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -4.17(-21.9%) |
2024 | -5.34(+216.0%) |
Date | Value |
---|---|
2023 | -1.69(-80.2%) |
2022 | -8.52(-65.9%) |
2021 | -24.99 |
FAQ
- What is Design Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Design Therapeutics?
- What is DSGN EV/EBITDA year-to-date change?
- What is Design Therapeutics EV/EBITDA year-on-year change?
What is Design Therapeutics EV/EBITDA?
The current EV/EBITDA of DSGN is -4.17
What is the all time high EV/EBITDA for Design Therapeutics?
Design Therapeutics all-time high EV/EBITDA is -1.04
What is DSGN EV/EBITDA year-to-date change?
Design Therapeutics EV/EBITDA has changed by +1.17 (+21.91%) since the beginning of the year
What is Design Therapeutics EV/EBITDA year-on-year change?
Over the past year, DSGN EV/EBITDA has changed by -2.18 (-109.55%)